To identify potential nuclear transporters controlling the nucleo-cytoplasmic distribution of the CRIP1–BRCA2–RAD51 complex, we performed a mass spectrometry (MS) analysis on the immunoprecipitates from CDDP- and DMSO-treated GC cells (Fig. 5C). Here, RAD51 is linked to gastric cancer.